Predictors of recurrent herpes simplex virus keratitis

被引:0
|
作者
Barron, BA
Edwards, K
Massare, SJ
McGovern, MS
Williams, D
Capps, SJ
Dragon, DM
Fitzmorris, CT
Graul, EE
Insler, MS
Kaufman, HE
Lacoste, AD
McCaa, CS
Selser, RE
Wagner, NJ
Yokubaitis, JA
Wilhelmus, KR
Todaro, LA
Woodside, SJ
Bowman, CB
Chodosh, J
Gilliam, RM
Goosey, JD
Jones, DB
Kirkland, C
Lehmann, RP
Matoba, AY
Pitts, RE
Scott, PD
Smith, SL
Wolf, TC
Yee, RW
Banuvar, S
Osaki, SY
Cohen, F
Barth, GP
Biswell, R
Cuningham, E
DeMartini, DR
Gritz, D
Hodge, W
Holsclaw, DS
Hwang, DG
Knox, CM
Lietman, T
Margolis, TP
Schwab, IR
Schwartz, L
Sherman, M
Silverstein, B
机构
[1] Jaeb Ctr Hlth Res, Tampa, FL 33613 USA
[2] Baylor Coll Med, Cullen Eye Inst, Houston, TX 77030 USA
[3] Louisiana State Univ, Med Ctr, Ctr Eye, New Orleans, LA 70112 USA
[4] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA
[5] Emory Univ, Ctr Eye, Atlanta, GA 30322 USA
[6] Univ Illinois, Ctr Eye, Chicago, IL 60680 USA
[7] Med Coll Wisconsin, Inst Eye, Milwaukee, WI 53226 USA
[8] Wills Eye Hosp, Philadelphia, PA USA
[9] Mt Sinai Med Ctr, New York, NY 10029 USA
关键词
acyclovir; epithelial keratitis; herpes simplex virus; herpetic eye disease; ocular herpes simplex virus infection; stromal keratitis;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. Determinants of the natural history of recurrent herpes simplex virus (HSV) keratitis have not been consistently established, We assessed how previous HSV eye disease affects the risk of recurrent HSV keratitis and evaluated whether demographic and other variables play any predictive role. Methods. Three hundred forty-six patients in the placebo group of the Herpetic Eye Disease Study's Acyclovir Prevention Trial who had experienced an episode of HSV eye disease in the previous year were followed up for 18 months. Recurrences were categorized according to the type of involvement. Relative rates of recurrence were compared for categories of demographic variables, types and number of previous ocular HSV episodes, previous nonocular HSV infection, and month of the year. Results. Fifty-eight (18%) of the 346 patients developed epithelial keratitis and 59 (18%) developed stromal keratitis during the 18 months of follow-up. Previous epithelial keratitis did not significantly affect the risk of epithelial keratitis (p = 0.84). In contrast, previous stromal keratitis increased the risk of stromal keratitis 10-fold (p < 0.001), and the risk was strongly related to the number of previous episodes (p < 0.001). Age, gender, ethnicity, and nonocular herpes were not significantly associated with recurrences, and no seasonal effects were observed. Conclusion. Among patients who experienced active ocular HSV disease in the previous year, a history of epithelial keratitis was not a risk factor for recurrent epithelial keratitis. In contrast, previous, especially multiple, episodes of stromal keratitis markedly increased the probability of subsequent stromal keratitis.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 50 条
  • [31] Update on Herpes simplex keratitis management
    Sibley, Daniel
    Larkin, Daniel F. P.
    EYE, 2020, 34 (12) : 2219 - 2226
  • [32] Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection
    Mastrolorenzo, A
    Tiradritti, L
    Salimbeni, L
    Zuccati, G
    INTERNATIONAL JOURNAL OF STD & AIDS, 1995, 6 (06) : 431 - 435
  • [33] Herpes simplex virus in children
    Richard J. Whitley
    Current Treatment Options in Neurology, 2002, 4 (3) : 231 - 237
  • [34] Geldanamycin is effective in the treatment of herpes simplex virus epithelial keratitis in a rabbit model
    Wu, Xing
    Tao, Peizhen
    Nie, Hongping
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (08): : 779 - 783
  • [35] Predictors of Invasive Herpes Simplex Virus Infection in Young Infants
    Cruz, Andrea T.
    Nigrovic, Lise E.
    Xie, Jianling
    Mahajan, Prashant
    Thomson, Joanna E.
    Okada, Pamela J.
    Uspal, Neil G.
    Mistry, Rakesh D.
    Garro, Aris
    Schnadower, David
    Kulik, Dina M.
    Curtis, Sarah J.
    Miller, Aaron S.
    Fleming, Alesia H.
    Lyons, Todd W.
    Balamuth, Fran
    Arms, Joseph L.
    Louie, Jeffrey
    Aronson, Paul L.
    Thompson, Amy D.
    Ishimine, Paul T.
    Schmidt, Suzanne M.
    Pruitt, Christopher M.
    Shah, Samir S.
    Grether-Jones, Kendra L.
    Bradin, Stuart A.
    Freedman, Stephen B.
    PEDIATRICS, 2021, 148 (03)
  • [36] In vivo immunofluorescence confocal microscopy of herpes simplex virus type 1 keratitis
    Kaufman, SC
    Laird, J
    Beuerman, RW
    OPHTHALMIC TECHNOLOGIES VI, PROCEEDINGS OF, 1996, 2673 : 2 - 5
  • [37] Recurrent lymphocytic meningitis by herpes simplex virus type 2
    Benchetrit, Andres G.
    Garcia, Julian L.
    Janota, Franco
    Solari, Ruben M.
    MEDICINA-BUENOS AIRES, 2019, 79 (06) : 513 - 515
  • [38] Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model
    Sasaki, Shin-ichi
    Miyazaki, Dai
    Haruki, Tomoko
    Yamamoto, Yukimi
    Kandori, Michiko
    Yakura, Keiko
    Suzuki, Hiroshi
    Inoue, Yoshitsugu
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (04) : 498 - 503
  • [39] Ocular surgery after herpes simplex and herpes zoster keratitis
    Kanclerz, Piotr
    Alio, Jorge L.
    INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (12) : 3599 - 3612
  • [40] Host responses to herpes simplex virus and herpes simplex virus vectors
    Hukkanen, Veijo
    Paavilainen, Henrik
    Mattila, Riikka K.
    FUTURE VIROLOGY, 2010, 5 (04) : 493 - 512